Table 2.
Research activities performed at each visit, and associated data collected for each Stage 1 and Stage 2 visit, during the AHHA Study.
|
Research activities at each visit and data derived as part of activity |
Stage 1 (Baseline) | Stage 2 (6M−36M) | Time required (Minutes) |
|---|---|---|---|
| Informed consent and overview of study | X | 45 | |
| Baseline questionnaire (self-administered, computer-assisted) | X | 45 | |
| Demographics | |||
| Lifetime sexual history | |||
| Lifetime medical history (including HIV related med history) | |||
| Lifetime lifestyle history (smoking, alcohol, recreational drugs, | |||
| exercise) | |||
| Recent sexual history (past 6 months) | |||
| Recent lifestyle history (past 6 months) | |||
| Recent medical history (past 6 months) | |||
| The Fried Frailty Phenotype (FFP)* | |||
| Follow-up questionnaire (self-administered, computer-assisted) | X | 30 | |
| Recent sexual history (past 6 months) | |||
| Recent lifestyle history (past 6 months) | |||
| Recent medical history (past 6 months) | |||
| The Fried Frailty Phenotype (FFP)* | |||
| Grip-strength test | X | X | 15 |
| The Fried Frailty Phenotype (FFP)* | |||
| 15-foot timed walk test | X | X | 15 |
| The Fried Frailty Phenotype (FFP)* | |||
| Blood collection | X | X | 15 |
| Markers of inflammation (IL-6, CRP, D-dimer) | |||
| Veterans Aging Cohort Study (VACS) Index (PLWH)** | |||
| CD4+, HIV viral load (PLWH) | |||
| Anal clinical exam | X | X | 45 |
| Type specific anal HPV DNA | |||
| Histologically confirmed HSIL | |||
| Type specific anal HPV DNA | |||
| Total baseline time requirement | 180 | ||
| Total 6M−36M time requirement | 120 | ||
6M−36M: 6 month to 36-month visits–occurring every 6 months, PLWH, participants living with HIV; IL-6, Interleukin-6; CRP, C-reactive protein.
*The FFP is comprised of 5 domains, 3 are assessed by questionnaire, 1 by grip-strength test, and 1 by 15-foot timed walk test.
**The VACS Index is comprised of CD4+ level, HIV-1 VL, hemoglobin, Aspartate Aminotransferase (AST) Alanine Aminotransferase (ALT), platelet count, creatinine level, HCV serostatus.